tradingkey.logo
tradingkey.logo
Search

Why Doximity Stock Is Skyrocketing Today

The Motley FoolNov 8, 2024 7:06 PM
facebooktwitterlinkedin
View all comments0

Shares of Doximity (NYSE: DOCS) rocketed 35% higher as of 1:45 p.m. ET Friday, according to data provided by S&P Global Market Intelligence, after the company reported fiscal second-quarter earnings for the period ended Sept. 30.

Home to the leading digital platform for healthcare professionals in the United States, Doximity grew sales and earnings per share by 20% and 47%, respectively, while providing improved guidance for the full year. Following the company's revenue growth decelerating from over 90% in 2021 to just 6% only two quarters ago, the market seems optimistic that Doximity's accelerated growth could be here to stay.

Doximity: Becoming more than the LinkedIn for medical professionals

Used by over 80% of U.S. physicians, 60% of nurse practitioners, and 90% of graduating med students, Doximity's reach in the healthcare community is unmatched.

Doximity offers a personalized news feed for its 2 million members -- which grew by double digits in Q2. The company set a new record for the number of articles read, highlighting its burgeoning engagement. Thanks to this engagement, the company's newsfeed is a precious marketing space for pharmaceutical companies and hospital systems, making it no surprise that Doximity places advertisements from the 20 biggest companies in each vertical.

However, Doximity now provides workflow solutions to 600,000 prescribers, and is quickly becoming much more than LinkedIn for medical professionals. With workflow solutions ranging from telehealth video calls and digital fax capabilities to scheduling and artificial intelligence (AI) assistants, Doximity is laser-focused on making the healthcare industry more efficient.

Doximity handled over 1 million prompts from its Doximity GPT solution -- for example, generating a letter to appeal an insurance denial-- allowing physicians to focus on patients, not paperwork.

With a net profit margin of 33%, Doximity's future looks bright as this ample funding will allow for continued innovations like these.

Don’t miss this second chance at a potentially lucrative opportunity

Ever feel like you missed the boat in buying the most successful stocks? Then you’ll want to hear this.

On rare occasions, our expert team of analysts issues a “Double Down” stock recommendation for companies that they think are about to pop. If you’re worried you’ve already missed your chance to invest, now is the best time to buy before it’s too late. And the numbers speak for themselves:

  • Amazon: if you invested $1,000 when we doubled down in 2010, you’d have $23,657!*
  • Apple: if you invested $1,000 when we doubled down in 2008, you’d have $43,034!*
  • Netflix: if you invested $1,000 when we doubled down in 2004, you’d have $429,567!*

Right now, we’re issuing “Double Down” alerts for three incredible companies, and there may not be another chance like this anytime soon.

See 3 “Double Down” stocks »

*Stock Advisor returns as of November 4, 2024

Josh Kohn-Lindquist has positions in Doximity. The Motley Fool has positions in and recommends Doximity. The Motley Fool has a disclosure policy.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

tradingkey.logo
* References, analysis, and trading strategies are provided by the third-party provider, Trading Central, and the point of view is based on the independent assessment and judgement of the analyst, without considering the investment objectives and financial situation of the investors.
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.